Skip to main content

Amgen Inc. (AMGN)

NASDAQ: AMGN · IEX Real-Time Price · USD
201.09
-2.88 (-1.41%)
At close: Nov 26, 2021 1:00 PM
201.20
0.11 (0.05%)
After-hours:Nov 26, 2021 4:29 PM EST
Market Cap113.27B
Revenue (ttm)25.77B
Net Income (ttm)5.61B
Shares Out563.27M
EPS (ttm)9.70
PE Ratio20.73
Forward PE11.44
Dividend$7.04 (3.50%)
Ex-Dividend DateNov 15, 2021
Volume4,261,577
Open205.63
Previous Close203.97
Day's Range200.52 - 206.00
52-Week Range200.47 - 276.69
Beta0.61
AnalystsBuy
Price Target244.81 (+21.7%)
Earnings DateNov 2, 2021

About AMGN

Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces the chance of infection due a low white blood cell count in patients cancer; Prolia to treat postmenopausal women with osteoporosis; Xgeva for skeletal-related events prevention; Otezla for the treatment o...

IndustryBiotechnology
Founded1980
CEORobert Bradway
Employees24,300
Stock ExchangeNASDAQ
Ticker SymbolAMGN
Full Company Profile

Financial Performance

In 2020, Amgen's revenue was $25.42 billion, an increase of 8.83% compared to the previous year's $23.36 billion. Earnings were $7.26 billion, a decrease of -7.37%.

Financial Statements

Analyst Forecast

According to 30 analysts, the average rating for Amgen stock is "Buy." The 12-month stock price forecast is 244.81, which is an increase of 21.74% from the latest price.

Price Target
$244.81
(21.74% upside)
Analyst Consensus: Buy

News

Should You Buy This Giant Biotech Stock?

Amgen beat analysts' earnings expectations in the third quarter, and its balance sheet remains admirable.

1 day ago - The Motley Fool

Amgen To Present At The 2021 Evercore ISI Healthcare Conference

THOUSAND OAKS, Calif., Nov. 24, 2021 /PRNewswire/ -- Amgen (NASDAQ:AMGN) will present at the 2021 Evercore ISI Healthcare Conference at 5:10 p.m.

3 days ago - PRNewsWire

Amgen To Present At The 2021 Piper Sandler Healthcare Conference

THOUSAND OAKS, Calif., Nov. 24, 2021 /PRNewswire/ -- Amgen (NASDAQ:AMGN) will present at the 2021 Piper Sandler Healthcare Conference at 1:00 p.m.

3 days ago - PRNewsWire

2 Dividend Stocks to Buy Right Now

These two drugmakers have a solid track record.

Other symbols:BMY
1 week ago - The Motley Fool

Amgen Awards The Bath Institute of Rheumatic Diseases $25,000 Through UPLIFT Innovation Challenge

THOUSAND OAKS, Calif., Nov. 17, 2021 /PRNewswire/ -- Amgen (NASDAQ:AMGN) today announced the awarding of a one-time $25,000 grant to the Bath Institute of Rheumatic Diseases (BIRD) as part of the Unders...

1 week ago - PRNewsWire

3 Big Pharma Stocks Trading Near 52-Week Lows

Currently, there are many indicators showing that the U.S. stock market is overvalued.

Other symbols:BMYNVS
1 week ago - GuruFocus

Amgen's (AMGN) KRAS Inhibitor Gets CHMP Nod for Lung Cancer

The CHMP gives a positive opinion on, and recommends approval to Amgen's (AMGN) KRAS inhibitor, Lumykras for the treatment of advanced non-small-cell lung cancer.

1 week ago - Zacks Investment Research

Hot Stocks To Buy Now? 4 Health Care Stocks To Know

These health care industry players continue to serve the masses amid the current pandemic.

Other symbols:CLOVCVSPFE
2 weeks ago - Stockmarketcom

LUMYKRAS® (sotorasib) Receives Positive Opinion From EMA CHMP For Patients With KRAS G12C-Mutated Advanced Non-Small ...

THOUSAND OAKS, Calif., Nov. 12, 2021 /PRNewswire/ -- Amgen (NASDAQ: AMGN) today announced the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) adopted a posit...

2 weeks ago - PRNewsWire

3 Pharma Stocks That Could Make You Richer in November (and Beyond)

Two of them have already been big winners for investors this year.

Other symbols:LLYPFE
2 weeks ago - The Motley Fool

Here Are the Highlights From Amgen's Q3 Results

The big biotech reported only modest sales growth.

2 weeks ago - The Motley Fool

Amgen To Present At The 2021 Annual Cowen IO Summit

THOUSAND OAKS, Calif., Nov. 10, 2021 /PRNewswire/ -- Amgen (NASDAQ:AMGN) will present at the 2021 annual Cowen IO Summit at 2:15 p.m.

2 weeks ago - PRNewsWire

3 Nasdaq Stocks to Buy and Hold for Years

There's no question that stocks in the Nasdaq composite index have seen massive gains over the last year and a half. Even after taking a back seat to cyclicals late last year, the index continues to hit...

Other symbols:QCOMWDAY
2 weeks ago - InvestorPlace

First And Only Randomized, Double-blind, Head-to-head Study Comparing Aimovig® (erenumab-aooe), An Anti-CGRP Pathway ...

THOUSAND OAKS, Calif., Nov. 8, 2021 /PRNewswire/ -- Amgen (NASDAQ:AMGN) today announced new data from the HER-MES study, the first and only head-to-head study of Aimovig® (erenumab-aooe), a calcitonin g...

2 weeks ago - PRNewsWire

5 Buy-Rated Biotech Stocks to Bolster Your Portfolio

Biotech stocks have been picking up steam lately and several positive catalysts could keep the wind at the industry's back. Here are five names analysts are bullish on right now.

Other symbols:BIIBGILDINCYREGN
2 weeks ago - Kiplinger

How Are Biotech ETFs Reacting to These Q3 Earnings Releases?

Let's take a look at some big biotechnological earnings releases to see if these will impact ETFs exposed to the space.

Other symbols:BBHBIIBGILDIBBXBI
3 weeks ago - Zacks Investment Research

Amgen Begins Construction On New Biomanufacturing Plant In Central Ohio

THOUSAND OAKS, Calif., Nov. 5, 2021 /PRNewswire/ -- Amgen (NASDAQ:AMGN) today announced the groundbreaking of its newest biomanufacturing plant, located in New Albany, Ohio.

3 weeks ago - PRNewsWire

Amgen CEO says U.S. Medicare out-of-pocket cap will improve access

A proposed cap on out-of-pocket drug costs for Medicare recipients would improve patient access, but allowing the U.S. government health plan for seniors to negotiate prices could limit innovation, Amge...

3 weeks ago - Reuters

Amgen (AMGN) Q3 Earnings Top, Sales View Tightened, Stock Down

Amgen (AMGN) beats Q3 estimates for both earnings and sales. It lowers the upper end of the sales guidance for 2021 while raising the earnings range.

3 weeks ago - Zacks Investment Research

2 Incredibly Cheap Dividend Stocks to Buy Now

Amgen and Bristol Myers Squibb are two top dividends stocks with bargain-basement valuations.

Other symbols:BMY
3 weeks ago - The Motley Fool

Amgen Q3 Earnings Saved By Higher Volumes Despite Pricing Pressure On Some Drugs

Amgen Inc's (NASDAQ: AMGN) Q3 revenues increased 4% to $6.71 billion, slightly beating the consensus of $6.68 billion. The increase is driven by higher unit demand, partially offset by lower net selling...

3 weeks ago - Benzinga

Amgen (AMGN) Q3 Earnings and Revenues Top Estimates

Amgen (AMGN) delivered earnings and revenue surprises of 10.66% and 0.13%, respectively, for the quarter ended September 2021. Do the numbers hold clues to what lies ahead for the stock?

3 weeks ago - Zacks Investment Research

Amgen: Q3 Earnings Insights

Amgen (NASDAQ:AMGN) reported its Q3 earnings results on Tuesday, November 2, 2021 at 04:00 PM. Here's what investors need to know about the announcement.

3 weeks ago - Benzinga

Amgen 3rd quarter profit beats, sales rise 4%

Amgen Inc on Tuesday reported a 4% increase in third-quarter revenue as the impact of the COVID-19 pandemic on drug prescriptions began to ease, but said prices for some of its drugs remained under pres...

3 weeks ago - Reuters

Amgen Reports Third Quarter 2021 Financial Results

THOUSAND OAKS, Calif., Nov. 2, 2021 /PRNewswire/ -- Amgen (NASDAQ:AMGN) today announced financial results for the third quarter of 2021.

3 weeks ago - PRNewsWire